Development of a claims-based algorithm to identify colorectal cancer recurrence
A partir des données des registres américains des cancers et de la base Medicare portant sur 174 patients atteints d'un cancer colorectal, cette étude analyse l'efficacité d'un algorithme permettant d'évaluer la récidive de cancer et d'estimer son association avec la survie globale
Purpose : To examine the validity of claims data to identify CRC recurrence and determine the extent to which misclassification of recurrence status affects estimates of its association with overall survival in a population-based administrative database.
Methods : We calculated the accuracy of claims data relative to medical records from one large tertiary hospital to identify CRC recurrence. We estimated the effect of misclassifying recurrence on survival by applying these findings to the linked SEER-Medicare data.
Results : Of 174 eligible CRC patients identified through medical records, 32 (18.4%) had a recurrence. A claims-based algorithm of secondary malignancy codes yielded a sensitivity of 81% and specificity of 99% for identifying recurrence. Agreement between data sources was almost perfect (kappa: 0.86). In a model unadjusted for misclassification, CRC patients with recurrence were 3.04 times (95% CI: 2.92 – 3.17) more likely to die of any cause than those without recurrence. In the corrected model, CRC patients with recurrence were 3.47 times (95% CI 3.06 - 4.14) more likely to die than those without recurrence.
Conclusion : Identifying recurrence in CRC patients using claims data is feasible with moderate sensitivity and high specificity. Future studies can use this algorithm with SEER-Medicare data to study treatment patterns and outcomes of CRC patients with recurrence.
Annals of Epidemiology , résumé, 2014